Skip to content Skip to Search
Skip navigation

ADQ injects new life into healthcare portfolio

BMG is a production service provider for vials and pre-filled syringes used for vaccines Creative Commons
BMG is a production service provider for vials and pre-filled syringes used for vaccines

ADQ, an Abu Dhabi-based investment company, today announced it has agreed to acquire one of Turkey’s leading producers of sterile injectable products as part of plans to build an integrated healthcare and life sciences platform in the UAE.

The company said it has entered into a definitive agreement to acquire Birgi Mefar Group (BMG), a production service provider for vials and pre-filled syringes used for vaccines. 

BMG also produces primary packaging ampoules and vials for other sterile injectables and specialises in the growing demand for drug lyophilisation – the freeze-drying process that removes water from a product after it is frozen and placed under a vacuum. 

The company exports to more than 30 countries, including markets across Europe and Asia.

“BMG’s diversified offering and manufacturing capabilities make the company a strategic addition to our growing portfolio as we continue to shape the UAE’s healthcare and life sciences platform,” Fahad Al Qassim, executive director, healthcare and life sciences portfolio at ADQ, said.

“Turkey is an important market for our investments, and BMG brings with it a strong presence throughout the pharmaceutical supply chain, from drug development and manufacturing to packaging and cold chain distribution.

“With this integrated capability we believe it can enhance local expertise and build on the UAE’s ability to manufacture and distribute quality health products as the region’s leading pharmaceutical hub.” 

Faik Somer, CEO at Birgi Mefar Group, added: “Joining ADQ’s portfolio is an exciting next step in our journey that will elevate our offering and enable us to scale in lucrative markets like the UAE and wider MENA region.

“With ADQ’s support we will be in a stronger position to deliver excellence in global contract development and manufacturing of sterile products that will ultimately generate long-term sustainable growth.” 

The deal will provide ADQ exposure to a fast-growing market of injectables and high-value treatments, such as vaccines as well as access to a wide customer network ranging from large multinationals to local and regional players. 

The acquisition will also enable BMG to join ADQ’s healthcare and life science portfolio that aims to enhance manufacturing, distribution and commercialisation capabilities, including the provision of sterile health products and injectable solutions.

Earlier this year ADQ acquired Acino, a Swiss-based pharmaceutical manufacturer with presence in more than 90 countries. 

In 2021 ADQ acquired Pharmax, a pharmaceutical manufacturer in the UAE, and Amoun, one of Egypt’s leading pharmaceutical companies.

ADQ also retains a minority stake in Biocon Biologics Limited, India’s largest biopharmaceutical company.

The transaction is subject to customary closing conditions, including regulatory approvals.

Established in 2018, ADQ’s investments span key sectors of the UAE’s economy including energy and utilities, food and agriculture, healthcare and life sciences, and mobility and logistics.

Latest articles

Miahona water tower

Saudi water major Miahona plans IPO

A water and wastewater infrastructure operator that pioneered the public-private partnership model in Saudi Arabia is planning an IPO that will put 30 percent of its shares on the market. Miahona Company intends to list on the main market of the Saudi Exchange after receiving approval from the Capital Market Authority last month. The company […]

The funding of Midas is among the 'biggest ever' Series A fund raise by a Turkish fintech

Turkish fintech Midas raises $45m for new products

Turkish fintech startup Midas has raised $45 million in equity funding to expand its services and launch new products. The new products include cryptocurrency trading, mutual funds and savings accounts. The funding is among the “biggest ever” Series A fund raise by a Turkish fintech and comes less than three years after Midas was launched.  […]

Plenary founder and director Paul Oppenheim, Plenary CEO David Lamming and Ahmed Ali AlShamsi, director of energy and utilities at ADQ

ADQ buys stake in Australian investment company

The UAE’s investment fund ADQ has acquired a 49 percent stake in Australian infrastructure investor Plenary Group as part of its expansion drive. The Abu Dhabi state-backed company will acquire all shares currently owned by Canadian pension fund Caisse de dépôt et placement du Québec, which will continue to invest in a range of Plenary’s […]

Over 400 global food brands are taking part in the SaudiFood Manufacturing show in Riyadh this month

Saudi Arabia’s food factory count rises to 1,300

The total number of food factories operated by the Saudi Authority for Industrial Cities and Technology Zones (Modon) has reached 1,300, across 36 cities. The increase signifies the growing capacity of the domestic food industry and its localisation efforts, the state-run Saudi Press Agency reported. Food industry companies have recorded a growth rate of more […]